Evaluation of a crosswalk between the European Quality of Life Five Dimension Five Level and the Menopause-Specific Quality of Life questionnaire

References

• Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, et al. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol 2005;105:1063–73
   PubMed Web of Science ®Google Scholar
• Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065–79
   PubMed Web of Science ®Google Scholar
• Crandall CJ, Aragaki AK, Cauley JA, McTiernan A, Manson JE, Anderson G, et al. Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials. Breast Cancer Res Treat 2012;132:275–85
   PubMed Web of Science ®Google Scholar
• Crandall CJ, Aragaki AK, Cauley JA, McTiernan A, Manson JE, Anderson GL, et al. Breast tenderness after initiation of conjugated equine estrogens and mammographic density change. Breast Cancer Res Treat 2012;131:969–79
   PubMed Web of Science ®Google Scholar
• Huber J, Palacios S, Berglund L, Hanggi W, Sathanandan SM, Christau S, et al. Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women. BJOG 2002;109:886–93
   PubMed Web of Science ®Google Scholar
• Abraham L, Humphrey L, Arbuckle R, Dennerstein L, Simon JA, Mirkin S, et al. Qualitative cross-cultural exploration of breast symptoms and impacts associated with hormonal treatments for menopausal symptoms to inform the development of new patient-reported measurement tools. Maturitas 2015;80:273–81
   PubMed Web of Science ®Google Scholar
• Arbuckle R, Humphrey L, Abraham L, Dennerstein L, Simon JA, Mirkin S, et al. Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement tools. Maturitas 2014;78:219–27
   PubMed Web of Science ®Google Scholar
• French L, Smith M, Holtrop J, Holmes-Rovner M. Hormone therapy after the Women's Health Initiative: a qualitative study. BMC Family Practice 2006;7:61
   PubMedGoogle Scholar
• Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 2011;20:1727–36
   PubMed Web of Science ®Google Scholar
• van Hout B, Janssen MF, Feng Y-S, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health 2012;15:708–15
   PubMed Web of Science ®Google Scholar
• Reenen Mv, Janssen B. EQ-5D-5L User Guide: Basic Information on How to Use the EQ-5D-5L Instrument. 2015
   Google Scholar
• Pickard AS, De Leon MC, Kohlmann T, Cella D, Rosenbloom S. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care 2007;45:259–63
   PubMed Web of Science ®Google Scholar
• Ferreira LN, Ferreira PL, Ribeiro FP, Pereira LN. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults. Health Qual Life Outcomes 2016;14:89
   PubMed Web of Science ®Google Scholar
• Janssen MF, Birnie E, Bonsel GJ. Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 2008;17:463–73
   PubMed Web of Science ®Google Scholar
• Janssen M, Birnie E, Haagsma J, Bonsel G. Comparing the Standard EQ-5D three-level system with a five-level version. Value Health 2008;11:275–84
   Web of Science ®Google Scholar
• Swinburn P, Lloyd A, Boye KS, Edson-Heredia E, Bowman L, Janssen B. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. Value in Health 2013;16:1156–62
   PubMed Web of Science ®Google Scholar
• Tran BX, Ohinmaa A, Nguyen LT. Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health Qual Life Outcomes 2012;10:1–8
   PubMed Web of Science ®Google Scholar
• Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161–75
   PubMed Web of Science ®Google Scholar
• ten Klooster PM, Oude Voshaar MA, Gandek B, Rose M, Bjorner JB, Taal E, et al. Development and evaluation of a crosswalk between the SF-36 physical functioning scale and Health Assessment Questionnaire disability index in rheumatoid arthritis. Health Qual Life Outcomes 2013;11:199
   PubMed Web of Science ®Google Scholar
• Tatlock S, Abraham L, Bushmakin A, Moffatt M, Williamson N, Arbuckle R, et al. Psychometric evaluation of two electronic daily diaries to assess breast pain/tenderness and vaginal spotting/bleeding associated with hormone therapy in postmenopausal women. Climacteric; accepted for publication, 2017
   Google Scholar
• Williamson N, Tatlock S, Arbuckle R, Abraham L, Moffatt M, Bushmakin A. Assessing the humanistic burden of menopausal symptoms and breast pain/tenderness and vaginal spotting/bleeding side effects of estrogen plus progestogen therapy among postmenopausal women in the US. Unpublished manuscript, 2017
   Google Scholar
• Sydora BC, Fast H, Campbell S, Yuksel N, Lewis JE, Ross S. Use of the Menopause-Specific Quality of Life (MENQOL) questionnaire in research and clinical practice: a comprehensive scoping review. Menopause (New York, NY) 2016;23:1038–51
   PubMed Web of Science ®Google Scholar
• Van Dole KB, DeVellis RF, Brown RD, Funk ML, Gaynes BN, Williams RE. Evaluation of the menopause-specific quality of life questionnaire: a factor-analytic approach. Menopause (New York, NY) 2012;19:211–5
   PubMed Web of Science ®Google Scholar
• Radtke JV, Terhorst L, Cohen SM. The Menopause-Specific Quality of Life (MENQOL) questionnaire: psychometric evaluation among breast cancer survivors. Menopause (New York, NY) 2011;18:289–95
   PubMed Web of Science ®Google Scholar
• Kulasingam S, Moineddin R, Lewis JE, Tierney MC. The validity of the menopause specific quality of life questionnaire in older women. Maturitas 2008;60:239–43
   PubMed Web of Science ®Google Scholar
• EuroQoL. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208
   PubMed Web of Science ®Google Scholar
• Räsänen P, Roine E, Sintonen H, Semberg-Konttinen V, Ryynänen O-P, Roine R. Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review. Inter J Technol Assess Health Care 2006;22:235–41
   PubMed Web of Science ®Google Scholar
• Pattanaphesaj J, Thavorncharoensap M. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes 2015;13:14
   PubMed Web of Science ®Google Scholar
• Sayah FA, Bansback N, Bryan S, Ohinmaa A, Poissant L, Pullenayegum E, et al. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 2016;25:1679–85
   PubMed Web of Science ®Google Scholar
• Heinemann L, Potthoff P, Schneider H. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes 2003;1:28
   PubMedGoogle Scholar
• Pinedo-Villanueva RA, Turner D, Judge A, Raftery JP, Arden NK. Mapping the Oxford hip score onto the EQ-5D utility index. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 2013;22:665–75
   PubMed Web of Science ®Google Scholar
• Bushmakin AG, Tatlock S, Williamson N, Moffatt M, Arbuckle R, Abraham L, et al. Development and evaluation of a crosswalk between the Eq-5d-5l and Menopause-Specific Quality of Life (Menqol) questionnaire in postmenopausal women. Value in Health 19:A178
   Web of Science ®Google Scholar
• Littell RC, Henry PR, Ammerman CB. Statistical analysis of repeated measures data using SAS procedures. Journal of Animal Science 1998;76:1216–31
   PubMed Web of Science ®Google Scholar
• Hooper D, Coughlan J, Mullen M. Structural equation modelling: guidelines for determining model fit. 2008;2:53–60
   Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioural Sciences. New York: Academic Press; 1977
   Google Scholar
• Williams RE, Levine KB, Kalilani L, Lewis J, Clark RV. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas 2009;62:153–9
   PubMed Web of Science ®Google Scholar
• Jia H, Lubetkin EI. The impact of obesity on health-related quality-of-life in the general adult US population. Journal of Public Health (Oxford, England) 2005;27:156–64
   PubMed Web of Science ®Google Scholar
• Heinemann L, DoMinh T, Strelow F, Gerbsch S, Schnitker J, Schneider H. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes 2004;2:67
   PubMedGoogle Scholar
• Dibonaventura MD, Chandran A, Hsu MA, Bushmakin A. Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom. Int J Womens Health 2013;5:261–9
   PubMedGoogle Scholar
• Whiteley J, Wagner JS, Bushmakin A, Kopenhafer L, Dibonaventura M, Racketa J. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity. Menopause (New York, NY) 2013;20:518–24
   PubMed Web of Science ®Google Scholar
• Askew RL, Kim J, Chung H, Cook KF, Johnson KL, Amtmann D. Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 2013;22:2769–76
   PubMed Web of Science ®Google Scholar